These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

442 related articles for article (PubMed ID: 9669266)

  • 21. Proarrhythmia.
    Friedman PL; Stevenson WG
    Am J Cardiol; 1998 Oct; 82(8A):50N-58N. PubMed ID: 9809901
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Maintenance of sinus rhythm with oral d,l-sotalol therapy in patients with symptomatic atrial fibrillation and/or atrial flutter. d,l-Sotalol Atrial Fibrillation/Flutter Study Group.
    Benditt DG; Williams JH; Jin J; Deering TF; Zucker R; Browne K; Chang-Sing P; Singh BN
    Am J Cardiol; 1999 Aug; 84(3):270-7. PubMed ID: 10496434
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Efficacy of Intravenous Sotalol for Treatment of Incessant Tachyarrhythmias in Children.
    Li X; Zhang Y; Liu H; Jiang H; Ge H; Zhang Y
    Am J Cardiol; 2017 May; 119(9):1366-1370. PubMed ID: 28283175
    [TBL] [Abstract][Full Text] [Related]  

  • 24. QT variability during initial exposure to sotalol: experience based on a large electronic medical record.
    Weeke P; Delaney J; Mosley JD; Wells Q; Van Driest S; Norris K; Kucera G; Stubblefield T; Roden DM
    Europace; 2013 Dec; 15(12):1791-7. PubMed ID: 23787903
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Sotalol: An important new antiarrhythmic.
    Anderson JL; Prystowsky EN
    Am Heart J; 1999 Mar; 137(3):388-409. PubMed ID: 10047618
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Medicamentous prevention after electric cardioversion of chronic atrial fibrillation. Goals and design of the PAFAC Study].
    Fetsch T; Burschel G; Breithardt G; Engberding R; Koch HP; Lukl J; Trappe HJ; Treese N
    Z Kardiol; 1999 Mar; 88(3):195-207. PubMed ID: 10355070
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Sotalol as first-line treatment for fetal tachycardia and neonatal follow-up.
    van der Heijden LB; Oudijk MA; Manten GT; ter Heide H; Pistorius L; Freund MW
    Ultrasound Obstet Gynecol; 2013 Sep; 42(3):285-93. PubMed ID: 23303470
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Prevention of supraventricular tachyarrhythmias after open heart operation by low-dose sotalol: a prospective, double-blind, randomized, placebo-controlled study.
    Pfisterer ME; Klöter-Weber UC; Huber M; Osswald S; Buser PT; Skarvan K; Stulz PM
    Ann Thorac Surg; 1997 Oct; 64(4):1113-9. PubMed ID: 9354537
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Sotalol. An updated review of its pharmacological properties and therapeutic use in cardiac arrhythmias.
    Fitton A; Sorkin EM
    Drugs; 1993 Oct; 46(4):678-719. PubMed ID: 7506652
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Canadian Cardiovascular Society atrial fibrillation guidelines 2010: rate and rhythm management.
    Gillis AM; Verma A; Talajic M; Nattel S; Dorian P;
    Can J Cardiol; 2011; 27(1):47-59. PubMed ID: 21329862
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Clinical efficacy of dofetilide for the treatment of atrial tachyarrhythmias in adults with congenital heart disease.
    Banchs JE; Baquero GA; Nickolaus MJ; Wolbrette DL; Kelleman JJ; Samii S; Grando-Ting J; Penny-Peterson E; Davidson WR; Young SK; Naccarelli GV; Gonzalez MD
    Congenit Heart Dis; 2014; 9(3):221-7. PubMed ID: 23947935
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Efficacy, safety, and tolerance of d-sotalol in patients with refractory supraventricular tachyarrhythmias.
    Sahar DI; Reiffel JA; Bigger JT; Squatrito A; Kidwell GA
    Am Heart J; 1989 Mar; 117(3):562-8. PubMed ID: 2919535
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Does Sotalol Still Have a Role in the Management of Arrhythmias?
    Semasinghe Bandaralage SP; Nirthanan S; Niranjan S
    Am J Ther; 2019; 26(1):e161-e169. PubMed ID: 27759583
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Flecainide and sotalol: a new combination therapy for refractory supraventricular tachycardia in children <1 year of age.
    Price JF; Kertesz NJ; Snyder CS; Friedman RA; Fenrich AL
    J Am Coll Cardiol; 2002 Feb; 39(3):517-20. PubMed ID: 11823091
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [QT prolongation and torsade de pointes tachycardia during therapy with maprotiline. Differential diagnostic and therapeutic aspects].
    Lentini S; Rao ML; Schröder R; Lüderitz B; Bauriedel G
    Dtsch Med Wochenschr; 2001 Dec; 126(49):1396-400. PubMed ID: 11740632
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Drug-induced torsade de pointes.
    Raehl CL; Patel AK; LeRoy M
    Clin Pharm; 1985; 4(6):675-90. PubMed ID: 2416504
    [TBL] [Abstract][Full Text] [Related]  

  • 37. New antiarrhythmic drug in pediatric use: sotalol.
    Pfammatter JP; Paul T
    Pediatr Cardiol; 1997; 18(1):28-34. PubMed ID: 8960489
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Implementation of an intravenous sotalol initiation protocol: Implications for feasibility, safety, and length of stay.
    Liu AY; Charron J; Fugaro D; Spoolstra S; Kaplan R; Lohrmann G; Gao X; Gay H; Passman R; Kim S; Lin AC; Chicos A; Arora R; Patil K; Pfenniger A; Knight BP; Verma N
    J Cardiovasc Electrophysiol; 2023 Mar; 34(3):502-506. PubMed ID: 36640424
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Assessment of Sotalol and Dofetilide Dosing at a Large Academic Medical Center.
    Ting C; Malloy R; Knowles D
    J Cardiovasc Pharmacol Ther; 2020 Sep; 25(5):438-443. PubMed ID: 32347108
    [TBL] [Abstract][Full Text] [Related]  

  • 40. A comparison of the long-term effects of sotalol and atenolol on QT interval and arrhythmias after myocardial infarction.
    Cobbe SM; Alexopoulos D; Winner SJ; McCaie CP; Cobbe PC; Johnston J
    Eur Heart J; 1988 Jan; 9(1):24-31. PubMed ID: 2450026
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 23.